Physician profile
Kylee J Graef
NPI 1538679840
$1,702.35
in general payments reported to CMS, 2019-2025
11 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $287 · 2023: $292 · 2024: $392 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $349.14 | 2021-2025 | Minimed 780g |
| Abbott Laboratories | $282.01 | 2022-2025 | Freestyle Libre 3, Freestyle Libre |
| Tandem Diabetes Care, INC. | $201.39 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $190.60 | 2021-2022 | |
| Dexcom, INC. | $174.12 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $128.63 | 2024 | Evenity |
| Insulet Corporation | $117.06 | 2024-2025 | Omnipod |
| Novo Nordisk INC | $110.77 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $99.07 | 2023 | |
| Corcept Therapeutics | $31.29 | 2023 | Korlym |
| Lilly USA, LLC | $18.27 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylee Graef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.